Belluscura PLC Secures £1.92 Million Funding
Company Announcements

Belluscura PLC Secures £1.92 Million Funding

Belluscura PLC (GB:BELL) has released an update.

Belluscura PLC, a UK-based medical device developer, has successfully raised approximately £1.92 million through a combination of £1.71 million in convertible loan notes and £0.21 million through new ordinary share subscriptions to support the sales growth of its portable oxygen concentrator devices, X-PLOR and DISCOV-R. The funds are anticipated to fuel the company’s expansion, particularly in the North American market, following positive sales trends and preliminary orders for their latest oxygen technology products. The fundraising is subject to shareholder approval at a forthcoming General Meeting.

For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskBelluscura PLC Sees Revenue Surge with New Device Launch
TipRanks UK Auto-Generated NewsdeskBelluscura Reports Revenue Surge Amidst Net Losses
TipRanks UK Auto-Generated NewsdeskTekcapital Reduces Stake in Belluscura PLC
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App